Land quota has been obtained
Industrial leading enterprises, Top 500 enterprises, "specialized, sophisticated, special and new" enterprises, etc.
More than 100 enterprises are located in the park with more than 30,000 employees, including various R&D institutions which focus their researching work on such fields as biological drugs, chemical drugs, traditional Chinese medicines, consistency evaluation on generic drugs, medical cosmetology instruments and natural products. In 2018, the total output value produced in the Park reached up to RMB 15.77 billion.
Some projects involving bio-engineering, genetic engineering and cell engineering, are included in the Life Science Center. Among these, it is determined that more than 17 projects will be settled in the IVD (in vitro diagnosis) industrial incubator, and 65% of these projects are foreign-funded with integrated medical resources nationwide to form a leading full-chain closed-loop IVD innovation incubation platform domestically.
The Zone solves the problems in infrastructure construction for settled enterprises by providing IVD standardized factory buildings, R&D laboratories and administrative office locations; meanwhile, provides one-package services such as property management
The projects involving bio-engineering, genetic engineering and cell engineering are all-round investment attraction ones in the fields of life science, bio-medicine, natural products, medical health care, medical instruments and medical logistics.
Fu Yongqiang 13655375931